PF-06741086 Multiple Dose Study in Severe Hemophilia

Inclusion Criteria

• •Severe hemophilia A or B (Factor VIII or Factor IX activity ≤ 1%), including patients with inhibitors to Factor VIII or Factor IX
• •Episodic (on-demand) treatment regimen prior to screening
• •At least 6 acute bleeding episodes during the 6-month period prior to screening